- Home
- RPRX vs TLN Comparison
RPRX vs TLN Comparison
Compare RPRX & TLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- TLN
- Stock Information
- Founded
- RPRX 1996
- TLN 2015
- Country
- RPRX United States
- TLN United States
- Employees
- RPRX N/A
- TLN N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- TLN Electric Utilities: Central
- Sector
- RPRX Health Care
- TLN Utilities
- Exchange
- RPRX Nasdaq
- TLN Nasdaq
- Market Cap
- RPRX 16.2B
- TLN 18.6B
- IPO Year
- RPRX 2020
- TLN N/A
- Fundamental
- Price
- RPRX $38.73
- TLN $380.98
- Analyst Decision
- RPRX Strong Buy
- TLN Strong Buy
- Analyst Count
- RPRX 3
- TLN 13
- Target Price
- RPRX $46.00
- TLN $415.38
- AVG Volume (30 Days)
- RPRX 2.9M
- TLN 925.9K
- Earning Date
- RPRX 11-05-2025
- TLN 11-05-2025
- Dividend Yield
- RPRX 2.16%
- TLN N/A
- EPS Growth
- RPRX N/A
- TLN N/A
- EPS
- RPRX 1.60
- TLN 4.55
- Revenue
- RPRX $2,349,553,000.00
- TLN $2,257,000,000.00
- Revenue This Year
- RPRX $36.16
- TLN $13.60
- Revenue Next Year
- RPRX $2.04
- TLN $72.74
- P/E Ratio
- RPRX $25.42
- TLN $84.75
- Revenue Growth
- RPRX 3.69
- TLN 11.95
- 52 Week Low
- RPRX $24.05
- TLN $158.08
- 52 Week High
- RPRX $41.24
- TLN $451.28
- Technical
- Relative Strength Index (RSI)
- RPRX 58.15
- TLN 41.97
- Support Level
- RPRX $36.03
- TLN $390.04
- Resistance Level
- RPRX $41.24
- TLN $410.91
- Average True Range (ATR)
- RPRX 1.17
- TLN 20.15
- MACD
- RPRX 0.30
- TLN -2.24
- Stochastic Oscillator
- RPRX 52.86
- TLN 42.93
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About TLN Talen Energy Corporation Common Stock
Talen Energy Corp is an independent power producer and energy infrastructure company. The company owns and operates approximately 10.7 gigawatts of power infrastructure in the United States. The group produces and sells electricity, capacity, and ancillary services into wholesale U.S. power markets, including PJM and WECC, with its generation fleet located in the Mid-Atlantic and Montana.